# Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

> **NCT03012971** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 1500 (actual)

## Conditions studied

- Elderly
- Surgery
- Analgesia
- Dexmedetomidine
- Long-term Outcome

## Interventions

- **DRUG:** Dexmedetomidine supplemented morphine analgesia
- **DRUG:** Morphine analgesia

## Key facts

- **NCT ID:** NCT03012971
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-06
- **Primary completion:** 2024-12-11
- **Final completion:** 2024-12-11
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03012971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03012971, "Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03012971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*